• 1
    FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynecol Obstet 2002;77:2857.
  • 2
    Bagshawe KD. Endocrinology and treatment of trophoblastic tumours. J Clin Pathol Suppl 1976;10:1404.
  • 3
    Hertz R, Li MC, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 1956;93:3616.
  • 4
    Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997;15:263643.
  • 5
    Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 2003;91:5527.
  • 6
    Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, et al. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer 2006;16:14328.
  • 7
    Lu WG, Ye F, Shen YM, Fu YF, Chen HZ, Wan XY, et al. EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. Int J Gynecol Cancer 2008;18:35762.
  • 8
    McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:183844.
  • 9
    Lurain JR, Elfstrand EP. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995;172:5749.
  • 10
    Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;174:191723.
  • 11
    Hoogland HJ, Arends JW, Blijham GH, Braat SH, de Haan J, van Krimpen C. Death from chemotherapy in gestational trophoblastic disease. Eur J Obstet Gynecol Reprod Biol 1988;29:16772.
  • 12
    Lurain JR, Brewer JI, Mazur MT, Torok EE. Fatal gestational trophoblastic disease: an analysis of treatment failures. Am J Obstet Gynecol 1982;144:3915.
  • 13
    Mazur MT, Lurain JR, Brewer JI. Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center. Cancer 1982;50:183346.
  • 14
    Yang JJ, Xiang Y, Wan XR, Li Q, He FQ, Yang XY. Analysis of death causes of gestational trophoblastic neoplasia patients. Zhonghua Fu Chan Ke Za Zhi 2006;41:4037.
  • 15
    Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010;376:71729.
  • 16
    Ten Kate-Booij MJ, Lammes FB. Choriocarcinoma in the Netherlands. Ned Tijdschr Geneeskd 1984;128:5661.
  • 17
    Werkgroep Oncologische Gynaecologie (WOG). Landelijke Richtlijn Persisterende trofoblast en choriocarcinoom. [] 2010 July 13 (version 1.3). Accessed 1 January 2012.
  • 18
    Ross GT, Stolbach LL, Hertz R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res 1962;22:10157.
  • 19
    Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:137385.
  • 20
    Franke HR, Risse EK, Kenemans P, Vooijs GP, Stolk JG. Epidemiologic features of hydatidiform mole in the Netherlands. Obstet Gynecol 1983;62:6136.
  • 21
    van de Kaa CA, Schijf CP, de Wilde PC, Hanselaar AG, Vooijs PG. The role of deoxyribonucleic acid image cytometric and interphase cytogenetic analyses in the differential diagnosis, prognosis, and clinical follow-up of hydatidiform moles. A report from the Central Molar Registration in The Netherlands. Am J Obstet Gynecol 1997;177:121929.
  • 22
    Lok CA, Ansink AC, Grootfaam D, van der Velden J, Verheijen RH, Ten Kate-Booij MJ. Treatment and prognosis of post term choriocarcinoma in The Netherlands. Gynecol Oncol 2006;103:698702.
  • 23
    Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:8549.
  • 24
    Lybol C, Thomas CM, Bulten J, van Dijck JA, Sweep FC, Massuger LF. Increase in the incidence of gestational trophoblastic disease in The Netherlands. Gynecol Oncol 2011;121:3348.
  • 25
    Kingdon SJ, Coleman RE, Hancock BW. Death from gestational trophoblastic neoplasia – any lessons to be learnt? CME J Gynaecol Oncol 2011. Abstract.
  • 26
    Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet 2009;374:4855.
  • 27
    Chittenden B, Ahamed E, Maheshwari A. Choriocarcinoma in a postmenopausal woman. Obstet Gynecol 2009;114:4625.
  • 28
    Desai NR, Gupta S, Said R, Desai P, Dai Q. Choriocarcinoma in a 73-year-old woman: a case report and review of the literature. J Med Case Rep 2010;4:379.
  • 29
    Fisher RA, Soteriou BA, Meredith L, Paradinas FJ, Newlands ES. Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins. Int J Gynecol Cancer 1995;5:6470.
  • 30
    Shahib N, Martaadisoebrata D, Kondo H, Zhou Y, Shinkai N, Nishimura C, et al. Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markers. Gynecol Oncol 2001;81:24753.
  • 31
    Alifrangis C, Agarwal RA, Short D, Harvey R, Sebire NJ, Fisher RA, et al. EMA/CO for high-risk gestational trophoblastic neoplasia (GTN): improved outcomes with induction low dose etoposide-cisplatin (EP) and genetic analysis. CME J Gynecol Oncol 2011. Abstract.
  • 32
    Keepanasseril A, Suri V, Prasad GR, Gupta V, Bagga R, Aggarwal N, et al. Management of massive hemorrhage in patients with gestational trophoblastic neoplasia by angiographic embolization: a safer alternative. J Reprod Med 2011;56:23540.
  • 33
    Lok CA, Reekers JA, Westermann AM, van der Velden J. Embolization for hemorrhage of liver metastases from choriocarcinoma. Gynecol Oncol 2005;98:5069.
  • 34
    Moodley M, Moodley J. Transcatheter angiographic embolization for the control of massive pelvic hemorrhage due to gestational trophoblastic disease: a case series and review of the literature. Int J Gynecol Cancer 2003;13:947.
  • 35
    Soper JT, Evans AC, Conaway MR, Clarke-Pearson DL, Berchuck A, Hammond CB. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol 1994;84:96973.
  • 36
    Miller JM Jr, Surwit EA, Hammond CB. Choriocarcinoma following term pregnancy. Obstet Gynecol 1979;53:20712.